Milk in Life Conditions (MiLC): Bacterial Composition of Human Milk Pumped and Stored in "Real-Life" Conditions
MiLC
3 other identifiers
interventional
52
1 country
1
Brief Summary
The MiLC trial is a randomized control trial of two different breast pump set-ups: mother's own and sterile. The objective of this trial is to investigate the bacterial composition of human milk pumped and stored in "real-life" conditions. To meet this objective, lactating mothers will fully express breast milk from one breast on two consecutive pumping sessions at home, once with the participant's own pumps and collection kits (own pump set-up) and once with a hospital-grade pump and disposable, sterile collection kits (sterile pump set-up). Randomization will be used to determine which pump participants use first. From the total volume of milk pumped during each pumping session, the researchers will collect 1 oz. Milk from both pumps will be stored at home and sampled on days 0, 2, 4, and 30 after expression for analysis of its bacterial composition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2017
CompletedFirst Posted
Study publicly available on registry
April 21, 2017
CompletedStudy Start
First participant enrolled
May 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 2, 2017
CompletedResults Posted
Study results publicly available
May 21, 2019
CompletedMay 21, 2019
April 1, 2019
4 months
April 6, 2017
April 30, 2019
April 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Bacterial Community Richness
Richness is the total number of different bacterial taxa detected in the sample. This metric will be assessed on data collected via high-throughput sequencing of the bacterial 16S rRNA gene present in milk.
0 days after pumping
Bacterial Community Diversity
Bacterial community diversity will be assessed using the the Shannon diversity index. The Shannon diversity index is a type of entropy measure and is a function of the distribution of the total number of organisms across all of the species. If S is the total number of species in the sample and p\_i is the number of organisms in the i-th species divided by the total number of organisms, then Diversity = -Σ p\_i log(p\_i). This metric will be assessed on data collected via high-throughput sequencing of the bacterial 16S rRNA gene present in milk.
0 days after pumping
Total Live Aerobic Bacterial Counts
Number of live total aerobic bacteria in milk assessed by aerobic culturing of milk on plate count agar. Reported as colony-forming units (CFU)/mL.
0 days after pumping
Study Arms (2)
Sterile pump set-up first
EXPERIMENTALParticipants will pump with sterile pump set-ups first. Approximately 3 hours later, participants will pump with their own pump set-ups.
Mother's Own pump set-up first
EXPERIMENTALParticipants will pump with their own pump set-ups first. Approximately 3 hours later, participants will pump with sterile pump set-ups.
Interventions
Medela symphony breast pump (model number 0240108) and disposable, sterile collection kits (model number 67399S).
Mother's own electric breast pump and own collection kit (previously used and cleaned at home using her usual practices).
Eligibility Criteria
You may qualify if:
- Lactating women over the age of 18 years
- Self-reported as healthy women and infants
- Use an electric breast pump
- Confident of ability to donate 1 oz of milk from one breast during each of two consecutive pumping sessions where pumping sessions are 3 hours (+/- 30 minutes) apart and between 0700-1100 hours.
- Able to store donated milk at home for 30 days
- Have infants who do not consume formula or only consume formula episodically as long as the most recent formula-feeding occurred \> 2 weeks before the day milk is pumped for this study.
You may not qualify if:
- Not confident of ability to donate 1 oz of milk from one breast during each of two consecutive pumping sessions, 3 hours (+/- 30 minutes) apart and between the hours of 0700-1100 hours.
- Infant consumption of formula in the past 2 weeks
- Current indication of breast infection (e.g., breast pain, discomfort, lumps, mastitis with fever, red streaks, or hard red portions of the breast)
- Breast pain that the woman does not consider "normal" for lactation/breastfeeding
- Signs/symptoms of acute illness in woman or infant in past 7 days including fever (rectal or temporal temperature ≥99.5 F), dark green nasal discharge, diarrhea (abrupt onset of 3 or more excessively "loose" stools in one day), vomiting (where infant vomiting is not associated with feeding), or severe cough.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cornell Universitylead
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator
- University of Idahocollaborator
- United States Department of Agriculture (USDA)collaborator
Study Sites (1)
Hay Laboratory, B75C Wing Hall, Cornell University
Ithaca, New York, 14853, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sarah Reyes
- Organization
- Cornell University
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen M. Rasmussen, ScD
Cornell University
- PRINCIPAL INVESTIGATOR
Anthony Hay, PhD
Cornell University
- STUDY DIRECTOR
Sarah Reyes, MS
Cornell University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2017
First Posted
April 21, 2017
Study Start
May 22, 2017
Primary Completion
October 2, 2017
Study Completion
October 2, 2017
Last Updated
May 21, 2019
Results First Posted
May 21, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will share
The researchers are currently undecided about how all the data from the study will be released but 16S rRNA data will be released through INSDC (the International Nucleotide Sequence Database Collaboration, which encompasses NCBI, EBI and DDBJ).